BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID of Ligand	PubChem SID of Ligand	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence	PDB ID(s) of Target Chain	UniProt (SwissProt) Recommended Name of Target Chain	UniProt (SwissProt) Entry Name of Target Chain	UniProt (SwissProt) Primary ID of Target Chain	UniProt (SwissProt) Secondary ID(s) of Target Chain	UniProt (SwissProt) Alternative ID(s) of Target Chain	UniProt (TrEMBL) Submitted Name of Target Chain	UniProt (TrEMBL) Entry Name of Target Chain	UniProt (TrEMBL) Primary ID of Target Chain	UniProt (TrEMBL) Secondary ID(s) of Target Chain	UniProt (TrEMBL) Alternative ID(s) of Target Chain
543563	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 35.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543567	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 17.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543571	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 29.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543575	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 380							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543579	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 89.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543583	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 49.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543587	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			<1.89							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543591	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 41.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543595	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 10.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543599	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 3.80							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543602	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12Cl2N4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	HJVCDCPLKNQXFO-UHFFFAOYSA-N	285538	N-cyclopropyl-3-(3,4-di-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 11::US10669279, Example 11::US9598421, Example 11	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 1.60							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285538&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700151	378169177							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543605	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 35.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543609	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 4.63							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543613	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 79.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543617	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 252							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543620	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-6-18-23)11-4-5-12-17-10-19-22(12)9-11/h1,3-6,9-10H,2,7-8H2	WFFUVTXNYNORQT-UHFFFAOYSA-N	285543	US10077269, Example 16::US10669279, Example 16::US9598421, Example 16::azetidin-1-yl[3-([1,2,4]tri-azolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 552							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285543&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875381	378169182							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543623	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 175							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543627	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 150							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543631	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 13.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543635	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 5.74							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543639	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 91.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543643	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 58.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543647	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 30.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543651	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 19.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543655	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 140							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543659	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 114							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543663	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 609							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543667	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 31.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543671	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 5.05							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543675	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 55.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543679	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 2670							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543683	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 419							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543687	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 53.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543691	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 83.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543695	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 48.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543699	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 6.99							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543703	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 75.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543706	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-3-4-11)15-16(22-14(21-15)2-1-6-19-22)10-8-13-12(18-9-10)5-7-24-13/h1-2,5-9,11H,3-4H2,(H,20,23)	XQQOHFBKZLHZIC-UHFFFAOYSA-N	285565	N-cyclopropyl-3-(furo[3,2-b]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 38::US10669279, Example 38::US9598421, Example 38	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 268							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285565&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700168	378169204							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543709	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 26.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543713	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 65.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543717	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 8.05							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543721	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 393							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543724	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-9-10(4-6-20-11)14-13(15(25)23-7-2-8-23)22-12-3-1-5-21-24(12)14/h1,3-6,9H,2,7-8H2	GXXYJNKWPOFUGD-UHFFFAOYSA-N	285570	US10077269, Example 43::US10669279, Example 43::US9598421, Example 43::azetidin-1-yl{3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 270							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285570&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875413	378169209							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543726	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1(F)F	InChI=1S/C16H10ClF3N4O/c17-9-4-3-8(6-10(9)18)14-13(15(25)22-11-7-16(11,19)20)23-12-2-1-5-21-24(12)14/h1-6,11H,7H2,(H,22,25)	LLYJCFVFPOZAJN-UHFFFAOYSA-N	285571	3-(4-chloro-3-fluorophenyl)-N-(2,2-difluorocyclopro-pyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 44::US10669279, Example 44::US9598421, Example 44	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 3.92							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285571&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875387	378169210							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543729	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 1.97							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543733	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 12.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543737	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 3.90							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543741	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 322							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543745	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 13.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543749	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 116							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543752	Cc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(5-6-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	TZEKFEDRWKCDSN-UHFFFAOYSA-N	285578	US10077269, Example 51::US10669279, Example 51::US9598421, Example 51::azetidin-1-yl[3-(4-chloro-3-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 42.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285578&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700177	378169217							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543755	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 37.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543759	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 63.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543763	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 107							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543767	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 200							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543771	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 43.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543774	Oc1ccccc1CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C21H17ClN4O2/c22-16-9-7-15(8-10-16)20-19(25-18-6-3-12-24-26(18)20)21(28)23-13-11-14-4-1-2-5-17(14)27/h1-10,12,27H,11,13H2,(H,23,28)	AQSPRZIQVZXKMZ-UHFFFAOYSA-N	285584	3-(4-chlorophenyl)-N-[2-(2-hydroxyphenyl)ethyl]imidazo[1,2-b]pyridazine-2-carboxamide,formate salt::US10077269, Example 57::US10669279, Example 57::US9598421, Example 57	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 236							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285584&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700182	378169223							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543776	Cc1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)no1	InChI=1S/C17H12ClN5O2/c1-10-9-13(22-25-10)20-17(24)15-16(11-4-6-12(18)7-5-11)23-14(21-15)3-2-8-19-23/h2-9H,1H3,(H,20,22,24)	WFHCBSIMFWEHOP-UHFFFAOYSA-N	285585	3-(4-chlorophenyl)-N-(5-methyl-1,2-oxazol-3-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 58::US10669279, Example 58::US9598421, Example 58	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 43.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285585&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700183	378169224							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543778	Cn1ncc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)n1	InChI=1S/C16H12ClN7O/c1-23-19-9-12(22-23)20-16(25)14-15(10-4-6-11(17)7-5-10)24-13(21-14)3-2-8-18-24/h2-9H,1H3,(H,20,22,25)	KUCAVVPPPHKSFZ-UHFFFAOYSA-N	285586	3-(4-chlorophenyl)-N-(2-methyl-2H-1,2,3-triazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 59::US10669279, Example 59::US9598421, Example 59	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 58.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285586&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700184	378169225							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543781	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 196							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543785	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 184							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543788	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2nccnc2c1	InChI=1S/C18H14N6O/c25-18(23-9-2-10-23)16-17(24-15(22-16)3-1-6-21-24)12-4-5-13-14(11-12)20-8-7-19-13/h1,3-8,11H,2,9-10H2	BGLGXXOVOLTBJL-UHFFFAOYSA-N	285589	US10077269, Example 62::US10669279, Example 62::US9598421, Example 62::azetidin-1-yl[3-(quinoxalin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone, formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 275							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285589&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700187	378169228							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543790	CC(=O)c1ccc(F)c(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H15FN4O2/c1-11(24)12-5-6-14(19)13(10-12)17-16(18(25)22-8-3-9-22)21-15-4-2-7-20-23(15)17/h2,4-7,10H,3,8-9H2,1H3	QERGAMABSQIOLR-UHFFFAOYSA-N	285590	1-{3-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-4-fluoro-phenyl}ethanone, formate salt::US10077269, Example 63::US10669279, Example 63::US9598421, Example 63	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 17.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285590&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875365	378169229							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543792	Cc1ccc(Cl)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(18)10-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	COVWSPFRFUFHGD-UHFFFAOYSA-N	285591	US10077269, Example 64::US10669279, Example 64::US9598421, Example 64::azetidin-1-yl[3-(5-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 24.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285591&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700189	378169230							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543794	Clc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(Cl)c1	InChI=1S/C16H12Cl2N4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	HDPIQIDAUQGIBP-UHFFFAOYSA-N	285592	US10077269, Example 65::US10669279, Example 65::US9598421, Example 65::azetidin-1-yl[3-(2,4-dichlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 71.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285592&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700188	378169231							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543796	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(C)c1Cl	InChI=1S/C18H17ClN4O/c1-11-6-7-13(12(2)15(11)19)17-16(18(24)22-9-4-10-22)21-14-5-3-8-20-23(14)17/h3,5-8H,4,9-10H2,1-2H3	FQEXMVRMBJXJHA-UHFFFAOYSA-N	285593	US10077269, Example 66::US10669279, Example 66::US9598421, Example 66::azetidin-1-yl[3-(3-chloro-2,4-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 41.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285593&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700190	378169232							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543798	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCOc2c1	InChI=1S/C18H16N4O3/c23-18(21-7-2-8-21)16-17(22-15(20-16)3-1-6-19-22)12-4-5-13-14(11-12)25-10-9-24-13/h1,3-6,11H,2,7-10H2	KQJWGLFCGGXBHN-UHFFFAOYSA-N	285594	US10077269, Example 67::US10669279, Example 67::US9598421, Example 67::azetidin-1-yl[3-(2,3-dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 59.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285594&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875392	378169233							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543801	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 35.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543804	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H11ClFN5O/c16-9-4-8(6-18-7-9)14-13(15(23)20-11-5-10(11)17)21-12-2-1-3-19-22(12)14/h1-4,6-7,10-11H,5H2,(H,20,23)/t10-,11+/m0/s1	ZHXHNZIKCBDMKP-WDEREUQCSA-N	285596	3-(5-chloropyridin-3-yl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 69::US10669279, Example 69::US9598421, Example 69	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 116							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285596&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700193	378169235							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543807	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 31.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543811	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 2.82							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543814	Cc1ccc(-c2c(nc3cccnn23)C(=O)N[C@@H]2C[C@@H]2F)c(F)c1	InChI=1S/C17H14F2N4O/c1-9-4-5-10(11(18)7-9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	LTEXTCILPHUJPK-QWHCGFSZSA-N	285599	N-[(1R,2S)-2-fluorocyclopro-pyl]-3-(2-fluoro-4-methyl-phenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 72::US10669279, Example 72::US9598421, Example 72	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 192							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285599&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700195	378169238							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543817	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 495							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543820	O=C(N1CCC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-5-19-23)11-9-17-12-4-6-18-22(12)10-11/h1,3-6,9-10H,2,7-8H2	RINAWWCARFNGLM-UHFFFAOYSA-N	285601	US10077269, Example 74::US10669279, Example 74::US9598421, Example 74::azetidin-1-yl[3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 225							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285601&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700198	378169240							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543823	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 75::US10669279, Example 75::US9598421, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 5.99							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543827	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::US10669279, Example 76::US9598421, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 5.43							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543831	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::US10669279, Example 77::US9598421, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 80.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543834	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-3-4-11)14-15(23-13(21-14)2-1-6-19-23)10-8-17-12-5-7-18-22(12)9-10/h1-2,5-9,11H,3-4H2,(H,20,24)	CWHUSRYDJYDLGV-UHFFFAOYSA-N	285608	N-cyclopropyl-3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 78::US10669279, Example 78::US9598421, Example 78	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 364							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285608&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875395	378169247							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543837	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 79::US10669279, Example 79::US9598421, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 190							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543840	Cc1ccc(cc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N	InChI=1S/C18H15N5O/c1-11-4-5-12(10-19)9-14(11)17-16(18(24)21-13-6-7-13)22-15-3-2-8-20-23(15)17/h2-5,8-9,13H,6-7H2,1H3,(H,21,24)	AYAPJFYFCDHLKN-UHFFFAOYSA-N	285610	3-(5-cyano-2-methylphenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 80::US10669279, Example 80::US9598421, Example 80	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 344							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285610&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875393	378169249							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543843	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 81::US10669279, Example 81::US9598421, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 9.34							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543847	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 82::US10669279, Example 82::US9598421, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 5.14							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543851	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::US10669279, Example 83::US9598421, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 5.39							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543855	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::US10669279, Example 84::US9598421, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 7.84							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543859	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 85::US10669279, Example 85::US9598421, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 87.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543863	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::US10669279, Example 86::US9598421, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 7.72							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543867	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 87::US10669279, Example 87::US9598421, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 173							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543871	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 88::US10669279, Example 88::US9598421, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 39.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543875	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 89::US10669279, Example 89::US9598421, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 333							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543879	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 90::US10669279, Example 90::US9598421, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 43.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543883	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::US10669279, Example 91::US9598421, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 36.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543887	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 92::US10669279, Example 92::US9598421, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 21.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543891	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 93::US10669279, Example 93::US9598421, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 276							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543895	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 94::US10669279, Example 94::US9598421, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 253							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543898	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1C	InChI=1S/C16H15ClN4O/c1-3-18-16(22)14-15(12-7-6-11(17)9-10(12)2)21-13(20-14)5-4-8-19-21/h4-9H,3H2,1-2H3,(H,18,22)	HRLMOSFOSQNGMI-UHFFFAOYSA-N	285625	3-(4-chloro-2-methylphenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 95::US10669279, Example 95::US9598421, Example 95	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 306							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285625&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875368	378169264							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543901	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 96::US10669279, Example 96::US9598421, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 33.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543905	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 97::US10669279, Example 97::US9598421, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 23.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543909	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 98::US10669279, Example 98::US9598421, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 62.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543913	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 99::US10669279, Example 99::US9598421, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 36.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543916	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C16H13ClF2N4O/c1-8(2)21-16(24)14-15(23-13(22-14)4-3-5-20-23)9-6-12(19)10(17)7-11(9)18/h3-8H,1-2H3,(H,21,24)	JMTGAAJHYHUEQI-UHFFFAOYSA-N	285630	3-(4-chloro-2,5-difluoro-phenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 100::US10669279, Example 100::US9598421, Example 100	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 49.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285630&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700207	378169269							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543919	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 101::US10669279, Example 101::US9598421, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 861							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543923	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 102::US10669279, Example 102::US9598421, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 103							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543927	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 103::US10669279, Example 103::US9598421, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 249							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6						
543931	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 104::US10669279, Example 104::US9598421, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]			 1.59							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6